SCHEMBL23867667

SCHEMBL23867667

Cc1cc(NC2=CC=C(N)CC2)nc(N2CCCC2)n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.46
▸ MAPT P10636 2/20 0.46
▸ GALR2 O43603 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ TAAR1 Q96RJ0 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ ROCK2 O75116 3/20 0.42
▸ PKM P14618 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ ROCK1 Q13464 1/20 0.40
▸ CCNE1 P24864 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ GBA1 P04062 1/20 0.40
▸ GALR1 P47211 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23859940 0.77 MAPT (0.62) LMNAMAPTGALR2ALDH1A1MAPK1
SCHEMBL11506640 0.71 GALR2 (0.66) LMNAMAPTGALR2MAPK1TAAR1
SCHEMBL1708189 0.70 KMT2A (0.56) MAPTALDH1A1MAPK1NPSR1HSD17B10
SCHEMBL22148449 0.69 HRH4 (0.58) ALDH1A1NPSR1HSD17B10KDM4EGBA1
SCHEMBL30788620 0.69 HRH4 (0.58) ALDH1A1NPSR1HSD17B10KDM4EGBA1
SCHEMBL13693076 0.68 KMT2A (0.55) LMNAMAPTALDH1A1MAPK1NPSR1
SCHEMBL13033934 0.66 KMT2A (0.56) MAPTALDH1A1MAPK1POLBNPSR1
SCHEMBL23867651 0.65 LMNA (0.53) LMNAMAPTGALR2ALDH1A1MAPK1
SCHEMBL17303793 0.65 ALDH1A1 (0.54) LMNAMAPTALDH1A1MAPK1TAAR1
SCHEMBL15830164 0.64 ALDH1A1 (0.52) LMNAMAPTALDH1A1MAPK1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback